You are here

Responses

Article menu
Download PDFPDF
Original articles
Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 22 March 2016
    Future implications

    The authors rightly point out in their introduction that there is evidence (reference 12 Gargiullo P et al N Engl J Med 2007; 356:1121-9) of loss of vaccine-induced immunity over time, and that Australia will likely have to adopt a two-dose varicella schedule, which is not the case currently. I wonder if the authors have any opinion on how this will impact future maternity care in 15-20 years time and whether this will see...

    Show More
    Conflict of Interest:
    None declared.
  • Published on: 22 March 2016
    Congenital and neonatal varicella in the United Kingdom
    • Janet E Berrington, Consultant neonatal paediatrician
    • Other Contributors:
      • Eleri Williams, Nicholas Embleton, Julia Clark

    We note with interest the paper from Khandaker (1) and colleagues on the reduction of congenital and neonatal varicella infections following the introduction of immunisation of 18 month old children in Australia from 2005. Using surveillance methodology similar to that of the British Paediatric Surveillance Unit (BPSU) rates of congenital varicella (per 100,000 live births with 95% CI) have fallen from 0.8 (0.3 to 1.8) t...

    Show More
    Conflict of Interest:
    None declared.